MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Biological therapies, such as MDX-010, work in different ways to stimulate the immune system and stop cancer cells from growing. This phase I/II trial is studying the side effects and best dose of MDX-010 and to see how well it works in treating patients with recurrent or refractory B-cell non-Hodgkin’s lymphoma.
创建时间：
2004-06-15
